@GCar - there is a clause stating they are able to ask the Court to waive the >50% SH requirement@ConnerEx - break fees are not payable if SH reject the merger
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%